Best Practices, LLC

Drug companies approach brand security issue head on, study shows

Published in Physician Law Weekly, September 1st, 2004

A recent U.S. Food and Drug Administration report cited that about 10% of all drugs worldwide are counterfeit. That can mean huge revenue losses, as much as $2 billion annually, for even a mid-sized pharmaceutical company, not to mention the significant damage such fraud inflicts on a company's brand image.

Best-in-class pharmaceutical companies employ comprehensive approaches that align such key cross-functional areas as sales, manufacturing and distribution, legal and security in the brand security battle, according to Best Practices, LLC, a pharmaceutical benchmarking and consulting firm.

Best Practices, LLC, recently undertook a study through its...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2004-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry